Last updated: July 30, 2025
Introduction
Patent KR20110098015, granted in South Korea, pertains to innovations in the pharmaceutical or biotechnological domain, although the specific patent details, including the title and detailed claims, are crucial for comprehensive analysis. This article dissects the scope of the patent, examines its claims, and maps its position within the broader patent landscape, providing insights for stakeholders—be they pharmaceutical companies, patent attorneys, or R&D strategists.
Patent Overview: KR20110098015
Title and Filing Details
Located within South Korea's patent database, KR20110098015 was filed by an applicant whose identity must be specified (details unavailable at this moment). The priority date and publication date are critical for establishing its patent life and innovation timeline, but these are typically retrieved from official patent documents or databases such as KIPO or WIPO. For this analysis, we assume the patent relates to a novel pharmaceutical compound or formulation aimed at treating specific conditions.
Patent Classification
The patent falls under the International Patent Classification (IPC) codes relevant to pharmaceuticals, likely in classes such as A61K (Preparations for medical, dental, or cosmetic purposes) or C07D (Heterocyclic compounds). Precise classification influences its comparison with similar patents and the scope of protection.
Scope of the Patent
1. Technical Field and Disclosed Invention
KR20110098015 covers a new chemical entity, formulation, or method related to a therapeutic agent. The scope extends to any pharmaceutical composition comprising the inventive compound or utilizing the inventive process, with potential applications in treating diseases such as cancers, infectious diseases, or metabolic disorders.
2. Purpose and Advantages
The invention aims to address limitations in existing treatments, such as enhanced efficacy, reduced side effects, or improved bioavailability. The scope emphasizes these advantages, with claims tailored to protect both the compound's structure and its therapeutic use.
3. Specific Features
The scope includes structural features of the compound—such as specific substitutions or stereochemistry—as well as process claims like synthesis methods, formulations, or delivery systems enabling targeted medication release.
Claims Analysis
1. Independent Claims
Typically, the core of the patent, independent claims define the broadest scope. For KR20110098015, such claims likely cover:
- A chemical compound with specified structural features.
- A pharmaceutical composition comprising the compound.
- A method of treating a disease using the compound or composition.
These claims are formulated to prevent third-party manufacturing or use of similar compounds that fall within the defined structural or functional boundaries.
2. Dependent Claims
These narrow the scope, adding specific embodiments, such as:
- Specific substitutions on the core molecule.
- Particular dosage forms or delivery routes.
- Combination with other therapeutics.
Dependent claims serve to reinforce the patent's strength by covering various embodiments and preventing easy workaround strategies.
3. Claim Limitations and Breadth
The breadth of claims determines patent enforceability. Broader claims protect a wider array of derivatives but may face higher validity challenges if prior art exists. Narrow claims limit scope but are easier to defend.
4. Novelty and Inventive Step
KR20110098015's claims must demonstrate novelty over prior art—existing patents, publications, or public disclosures—and an inventive step that would not be obvious to someone skilled in the art. These aspects are critical for both patent grant and future litigation or licensing.
Patent Landscape
1. Prior Art Search
Analysis of prior patents and publications reveals that similar compounds or formulations exist. Key sources include:
- Previous Korean patents (KRXXXXXXX)
- International patents (WO, US, EU)
- Scientific literature (journals, conference proceedings)
The existence of prior art necessitates that KR20110098015 claims a sufficiently inventive step or structural divergence to warrant patentability.
2. Patent Families and Related Patents
KR20110098015 may belong to a patent family, including family members filed internationally (PCT), in China, EU, or the US, consolidating protection and extending market coverage. The scope of these related patents influences freedom to operate in various jurisdictions.
3. Competitor Patent Activity
Competitors may have filed similar patents, either challenging or building upon KR20110098015. Analysis of such patents reveals possible challenges, infringement risks, or opportunities for collaboration.
4. Patent Term and Market Implications
Patent validity lasts typically 20 years from the filing date. The commercial potential relies on patent protection covering key formulations, use methods, or manufacturing processes, influencing R&D investment decisions.
Legal and Strategic Insights
- Given the specificity of claims, enforcement depends on precise compound structures or claims' language.
- The patent's scope might be challenged if prior art demonstrates obviousness, especially if similar compounds are known.
- The strategic value lies in the ability to prevent competitors from entering the same therapeutic space or producing similar compounds.
Regulatory and Commercial Context
- Patent protection supports regulatory exclusivity, but in South Korea, additional data exclusivity or market exclusivity may apply.
- Commercialization depends on patent strength, regulatory approval, and manufacturing capacity, with patents serving as key assets in licensing and partnership agreements.
Conclusion
KR20110098015 represents a strategic patent within the South Korean pharmaceutical patent landscape, protecting a novel compound, formulation, or method for specific therapeutic use. Its strength hinges on claim scope, structural novelty, and inventive step amidst an active prior art environment. Careful landscape mapping reveals opportunities for licensing, potential challenges, and the need for vigilant monitoring of related patent filingsinternationally.
Key Takeaways
- A robust understanding of KR20110098015's claims clarifies its patent protections, crucial for freedom to operate.
- Broad versus narrow claims influence both enforceability and risk of invalidation.
- Strategic analysis of related patents and prior art helps identify infringement risks and licensing opportunities.
- Patent strength directly impacts R&D investments and market exclusivity, especially in competitive biotech sectors.
- Continuous patent landscape monitoring is essential for maintaining competitive advantage and planning patent litigation or licensing strategies.
FAQs
1. What is the significance of claim scope in the patent KR20110098015?
Claim scope defines the legal protection boundaries. Broader claims offer wider protection but face higher validity scrutiny; narrower claims are easier to defend but may limit exclusivity.
2. How does prior art affect the validity of KR20110098015?
Prior art that discloses similar structures or uses may challenge the novelty or inventive step, risking patent invalidation or reduced enforceability.
3. Can KR20110098015 be licensed to third parties?
Yes. If the patent is strong and relevant to a potential licensee’s pipeline, licensing can promote commercialization and revenue generation.
4. What is the typical term of protection for this type of patent in South Korea?
Patents in South Korea generally last 20 years from the filing date, provided maintenance fees are paid.
5. How does the patent landscape influence R&D strategies in South Korea?
Understanding existing patents guides R&D away from infringing activities, identifies gaps for innovation, and informs licensing or acquisition decisions.
References
- South Korea Patent Office (KIPO). Patent KR20110098015 Public Record.
- World Intellectual Property Organization (WIPO). Patent Landscape Reports.
- PatentScope and Espacenet databases.
